The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Identifying germline genetic alterations or environmental factors associated with bilateral germ cell tumor (GCT).
 
Jack Patrick Gleeson
Honoraria - IQVIA; Janssen
 
Emily Harrold
Consulting or Advisory Role - Pfizer
 
Maria Bromberg
No Relationships to Disclose
 
Zalak Patel
No Relationships to Disclose
 
Andrea Knezevic
Consulting or Advisory Role - ByHeart
 
Tinu Thomas
No Relationships to Disclose
 
Vignesh Ravichandran
No Relationships to Disclose
 
Christina Tran
Research Funding - PCCTC (Inst)
 
Deborah Silber
No Relationships to Disclose
 
Brett Stewart Carver
No Relationships to Disclose
 
Richard Matulewicz
No Relationships to Disclose
 
Deaglan Joseph McHugh
Consulting or Advisory Role - Progenics
 
Dean F. Bajorin
Consulting or Advisory Role - Bristol Myers Squibb Foundation; Dragonfly Therapeutics; Fidia Farmaceutici S. p. A.; Merck
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Merck (Inst); Novartis (Inst); Seattle Genetics/Astellas (Inst)
Travel, Accommodations, Expenses - Merck
 
George J. Bosl
No Relationships to Disclose
 
Samuel Aaron Funt
Employment - ByHeart (I)
Stock and Other Ownership Interests - Allogene Therapeutics; Doximity; IconOVir Bio; Kite, a Gilead company; Kronos Bio; Neogene Therapeutics; Urogen pharma; Vida Ventures
Consulting or Advisory Role - Immunai; Merck
Research Funding - AstraZeneca (Inst); Decibel Therapeutics (Inst); Genentech/Roche (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb
 
Vijai Joseph
Patents, Royalties, Other Intellectual Property - DIAGNOSIS & TREATMENT OF ERCC3-MUTANT CANCER Inventors: Vijai Joseph, Sabine Topka, Kenneth Offit US National Stage Patent Application No.: 16/493,214 Filing Date: September 11, 2019 (Inst)
 
Zsofia Kinga Stadler
Consulting or Advisory Role - Adverum (I); Alcon (I); Gyroscope (I); Neurogene (I); Regenxbio (I)
 
Darren R. Feldman
Consulting or Advisory Role - Cigna
Research Funding - Astellas Pharma; Decibel Therapeutics (Inst); Seagen
Other Relationship - UpToDate